tiprankstipranks
T-Mobile Expands 5G Coverage; Street is Bullish
Market News

T-Mobile Expands 5G Coverage; Street is Bullish

T-Mobile released preliminary fourth quarter and full-year 2020 results yesterday that highlighted postpaid net additions of 5.5 million customers for the year. This represents the highest increase in postpaid customers in the company’s history.

Don't Miss our Black Friday Offers:

T-Mobile (TMUS) expanded its 5G network leadership and now reaches 280 million people. The company surpassed its aggressive goal to cover 100 million Americans with Ultra Capacity 5G’s super-fast speeds by the end of 2020, reporting that 106 million Americans now have access to its 5G capabilities.

In comparison, Verizon’s Ultra Wideband 5G only covers 2 million people, which further underlines T-Mobile’s dominance in the 5G environment.

“Our focus on bringing unmatched value and experience to customers while building and delivering the nation’s best 5G network paid off with record-breaking results in 2020 (5.5 million new postpaid customers!) – and we continue to be the growth leader in wireless,” said Mike Sievert, T-Mobile CEO.

Sievert added, “Our 5G leadership position is getting stronger every day. We set some huge goals in 2020 that some thought were impossible, but we smashed them. Today, T-Mobile’s high speed Ultra Capacity 5G covers over 50 times more people than Verizon and it’s growing.”

Preliminary fourth quarter revenue beat analyst expectations of $19.86 billion, coming in at $19.91 billion, while earnings per share of $0.4823 missed the Street’s $0.4848 call. (See TMUS stock analysis on TipRanks)

Yesterday, Oppenheimer analyst Timothy Horan assigned a Buy rating on T-Mobile, setting his price target at $160. This implies upside potential of around 22% from current levels.

Horan believes that TMUS is building the only true 5G network on 80MHz of this spectrum and has a two-year-or-so market advantage over its competitors with a 10x improvement in speed.

Consensus among analysts is a Strong Buy based on 14 Buys and 2 Holds. The average price target of $146.13 suggests around 11% upside potential over the next 12 months.

Related News:
Walgreens Accelerates Investment in VillageMD to Ramp Up Rollout of Clinics
Carnival’s Cruise Lines Extend Pause in Operations; Street Remains Sidelined
Moderna’s Covid-19 Vaccine Wins EU Approval; Top Analyst Lifts PT

Go Ad-Free with Our App